Publisher's Synopsis
Liposomal drug and gene delivery systems have found success in clinical applications due to their biodegradable, biocompatible, non-toxic, and non-immunogenic nature. To underscore their importance in healthcare, in the fight against SARS-CoV-2 virus, lipid-based nanoparticular formulations of mRNA and DNA based vaccines have been developed via academic and industry collaboration. Aimed at newcomers and established researchers alike, this book provides a comprehensive coverage of the field. Each chapter emphasizes design principles and concludes with highlighting unmet translational challenges. Topics covered include up-scaling liposome preparation, FDA approved liposomal drug delivery systems (LDDS) for cancer and non-cancerous diseases; liposomes in non-viral gene therapy; receptor selective LDDS for targeted cancer therapy; liposomal delivery of DNA and mRNA vaccines and liposomes for combination therapy.Whilst there are many review articles, this book brings together information and explains the complex science in an accessible manner.Written for an interdisciplinary audience, this book is an up-to-date resource for this important and vibrant research field.
